12:00 AM
 | 
Mar 25, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Aubagio teriflunomide regulatory update

EMA's CHMP issued a positive opinion recommending approval of an MAA for Aubagio teriflunomide from Sanofi to treat relapsing-remitting multiple sclerosis...

Read the full 83 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >